Ovarian Cancer
GCT1184-07: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer
- Details
ClinicalTrials.gov ID:
NCT07564141
Diagnosis Type:
NA
USOR Number:
- Address
,
P: